average weight loss on glp 1 Hidden Risks of GLP-1 Inhibitors: Muscle and "Ozempic Face" Patients with Higher Initial BMIs
Description
Since GLP-1 therapy typically reduces portion sizes by about 50%, making every bite count is crucial
Allulose and GLP-1 Secretion: What In Vitro and Animal Studies Reveal In vitro and rodent studies suggest allulose may trigger GLP-1 secretion from intestinal L-cells more robustly than glucose, possibly by modulating sweet taste receptors (TAS1R2/TAS1R3) or metabolic sensors
Genetic insight does not guarantee treatment success but may reduce trial-and-error treatment selection
If youve been following the rise of GLP-1s as obesity drugs, this is a story worth watching
